AVCRFPharmaceutical PreparationsFiscal year ends December 31
Avricore Health Inc.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
Avricore Health Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Sale of products [Member] | C$2.45M | C$1.91M | C$1.55M | C$122.81K | C$33.03K | 52.6% | +28.7% |
| Lease and service [Member] | C$2.33M | C$1.58M | C$222.41K | – | – | 50.1% | +47.7% |
By region
From the segment and revenue-disaggregation notes of Avricore Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.